CRP was reduced in patients from all three categories, TNF-α was reduced in patients with CFS and psoriasis, and IL-6 was reduced in those with UC and CFS all as compared to placebo. This evidence concerns the gene IL6 and myalgic encephalomeyelitis/chronic fatigue syndrome.